KLOW Blend dosing schedule
Human schedule
Controlled data on this compound are limited. The regimens below were gathered from public sources online (studies and protocols) and are given as a reference, not a usage plan.
KLOW is a combined blend (BPC-157, TB-500, KPV, GHK-Cu; ~80 mg per vial) that protocols administer subcutaneously after reconstitution with bacteriostatic water. The figures below are a generalized reference drawn from public community protocols, not clinical trials.
This is a concise reference to regimens described for adults; it is not an individual prescription.
| Period / condition | Dose | Escalation |
|---|---|---|
| Start | ~2 mg total blend per day, subcutaneous | Starting dose |
| Main regimen | 4–6 mg total per day | Increase if needed |
| Intensive | up to 8 mg total per day | Maximum in this schedule |